Literature DB >> 16932590

Myotonia congenita--a cause of muscle weakness and stiffness.

Nicolas Chrestian1, Jack Puymirat, Jean-Pierre Bouchard, Nicolas Dupré.   

Abstract

BACKGROUND: A 56-year-old woman was referred to a neurogenetic clinic with a history of stiffness and transient weakness. A previous needle electromyogram had confirmed the presence of myotonia, but a muscle biopsy had revealed no evidence of dystrophy. INVESTIGATIONS: Neurological examination, electrophysiological studies and genetic testing. DIAGNOSIS: Recessive myotonia congenita (Becker's disease). MANAGEMENT: Explanation of the nature of the disease and treatment with mexiletine 200 mg twice daily.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16932590     DOI: 10.1038/ncpneuro0239

Source DB:  PubMed          Journal:  Nat Clin Pract Neurol        ISSN: 1745-834X


  2 in total

1.  Improving the understanding of how patients with non-dystrophic myotonia are selected for myotonia treatment with mexiletine (NaMuscla): outcomes of treatment impact using a European Delphi panel.

Authors:  Ann-Marie Chapman; Marieke Schurer; Laure Weijers; Amer Omar; Hiba Lee; Alla Zozulya Weidenfeller; Crispin Ellis; Shaneil Sonecha; Christiane Schneider-Gold
Journal:  BMC Neurol       Date:  2021-12-01       Impact factor: 2.474

2.  In vivo evaluation of antimyotonic efficacy of β-adrenergic drugs in a rat model of myotonia.

Authors:  Jean-François Desaphy; Teresa Costanza; Roberta Carbonara; Diana Conte Camerino
Journal:  Neuropharmacology       Date:  2012-09-18       Impact factor: 5.250

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.